byiShook Opinion
Sep 4, 2024 - 11:00
Ascendis Pharma stock tumbled Wednesday after the firm cut its outlook for its human growth hormone amid marketwide price struggles. The post Ascendis Pharma Undercuts 50-Day Line After Pricing Fiasco Prompts Guidance Cut appeared first on Investor's Business Daily.
Ascendis Pharma stock tumbled Wednesday after the firm cut its outlook for its human growth hormone amid marketwide price struggles.
The post Ascendis Pharma Undercuts 50-Day Line After Pricing Fiasco Prompts Guidance Cut appeared first on Investor's Business Daily.